Legacy Capital Group California, Inc. Moderna, Inc. Transaction History

Legacy Capital Group California, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$101.21 - $166.61 $173,979 - $286,402	1,719 New	1,719 $204 Million
Q2 2023 Aug 10, 2023	BUY	$118.5 - $160.53 $7,939 - $10,755	67 Added 4.03%	1,731 $210 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $225,738 - $327,841	1,664 New	1,664 $256 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Legacy Capital Group California, Inc., based on Form 13F filings with the SEC.

Stay updated on Legacy Capital Group California, Inc. with notifications on news.